National Health Determination under paragraph 98C(1)(b) Amendment 2015 (No. 11) (PB 119 of 2015) (Cth)

PB 119 of 2015

National Health Determination under paragraph 98C(1)(b) Amendment 2015
(No. 11)
_____________________________________________________________________

I, PENNY SHAKESPEARE, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.

Dated 21 December 2015

PENNY SHAKESPEARE
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health

1              Name of Instrument

(1)This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2015 (No. 11).

(2)This Instrument may also be cited as PB 119 of 2015.

2              Commencement  

This instrument commences on 1 January 2016.

3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)

Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).

Schedule 1            Amendments

1. Schedule 4, omit entry for Atorvastatin and ezetimibe

2. Schedule 4, omit entry for Chloramphenicol

3. Schedule 4, entry for Glucose Indicator—Blood

   omit:

Test strips, 100 (GoodLife)

1. Schedule 4, entry for Hydrocortisone

   (a)   omit:

Cream containing hydrocortisone acetate 10 mg per g, 30 g

(b)   omit:

Ointment containing hydrocortisone acetate 10 mg per g, 30 g

1. Schedule 4, omit entry for Nystatin